SCHEMBL3666568

SCHEMBL3666568

N#Cc1ccc(CN2CCC(NC(=O)c3cc4ccc(OC5CCN(c6ccc(C(F)(F)F)cc6)CC5)cc4o3)CC2I)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKAA2 P54646 6/20 0.40
EPHX2 P34913 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
AR P10275 1/20 0.39
PRKAB2 O43741 3/20 0.39
PRKAG1 P54619 3/20 0.39
PRKAA1 Q13131 3/20 0.39
PRKAG3 Q9UGI9 3/20 0.39
PRKAG2 Q9UGJ0 3/20 0.39
PRKAB1 Q9Y478 3/20 0.39
CYP3A4 P08684 1/20 0.39
SLC6A4 P31645 1/20 0.39
DRD4 P21917 1/20 0.38
GPBAR1 Q8TDU6 3/20 0.38
SLC6A5 Q9Y345 2/20 0.37
CETP P11597 2/20 0.37
CCR2 P41597 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3666017 0.93 PRKAA2 (0.40) PRKAA2EPHX2MAOAMAOBAR
SCHEMBL3665362 0.92 PRKAA2 (0.40) PRKAA2EPHX2SLC6A4DRD4SLC6A5
SCHEMBL3667429 0.91 SLC6A4 (0.40) PRKAA2ARSLC6A4DRD4SLC6A5
SCHEMBL649554 0.89 PRKAA2 (0.51) PRKAA2EPHX2MAOAMAOBPRKAB2
SCHEMBL3665902 0.89 AR (0.41) PRKAA2EPHX2ARSLC6A4DRD4
SCHEMBL3665359 0.87 UTS2R (0.45) PRKAA2EPHX2ARPRKAB2PRKAG1
SCHEMBL3662664 0.86 SLC6A5 (0.46) SLC6A4DRD4SLC6A5
SCHEMBL3666339 0.86 SLC6A4 (0.40) PRKAA2ARSLC6A4DRD4SLC6A5
SCHEMBL3664005 0.85 PRKAA2 (0.45) PRKAA2EPHX2PRKAB2PRKAG1PRKAA1
SCHEMBL3802167 0.85 CHRM4 (0.40) PRKAA2EPHX2PRKAB2PRKAG1PRKAA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231600-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS Rigel Pharmaceuticals, Inc. (US) 2010-09-29 EP claimed
WO-2009065131-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS RIGEL PHARMACEUTICALS, INC. (US) 2009-05-22 WO claimed